Prevention of meningococcal disease by group C polysaccharide vaccine.
D001428:Bacterial Vaccines / Q000009:adverse effects; D002353:Carrier State / Q000517:prevention & control; D002986:Clinical Trials as Topic; D006801:Humans; D008297:Male; D008589:Meningococcal Infections / Q000517:prevention & control*; D008887:Military Medicine; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology / Q000302:isolation & purification; D011135:Polysaccharides, Bacterial; D012703:Serotyping; D014481:United States; D014611:Vaccination
D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial